160 related articles for article (PubMed ID: 15241239)
21. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
[TBL] [Abstract][Full Text] [Related]
23. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.
Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA
Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
[TBL] [Abstract][Full Text] [Related]
25. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
26. Integrated Analysis of Transcriptome and Differential Methylation of Neurofibromatosis Type 2 Vestibular Schwannomas.
Shi J; Lu D; Gu R; Xie J; Yu L; Sun X; Zhang Y
World Neurosurg; 2022 Jan; 157():e66-e76. PubMed ID: 34587518
[TBL] [Abstract][Full Text] [Related]
27. Deregulated genes in sporadic vestibular schwannomas.
Cayé-Thomasen P; Borup R; Stangerup SE; Thomsen J; Nielsen FC
Otol Neurotol; 2010 Feb; 31(2):256-66. PubMed ID: 19816230
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the global profile of genes expressed in cervical epithelium by Serial Analysis of Gene Expression (SAGE).
Pérez-Plasencia C; Riggins G; Vázquez-Ortiz G; Moreno J; Arreola H; Hidalgo A; Piña-Sanchez P; Salcedo M
BMC Genomics; 2005 Sep; 6():130. PubMed ID: 16171524
[TBL] [Abstract][Full Text] [Related]
29. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.
Aghi M; Kluwe L; Webster MT; Jacoby LB; Barker FG; Ojemann RG; Mautner VF; MacCollin M
J Neurosurg; 2006 Feb; 104(2):201-7. PubMed ID: 16509493
[TBL] [Abstract][Full Text] [Related]
30. [Neurotrophic factor expression in vestibular schwannoma. An overview].
Diensthuber M; Lenarz T; Stöver T
Laryngorhinootologie; 2006 Oct; 85(10):731-7. PubMed ID: 16612755
[TBL] [Abstract][Full Text] [Related]
31. [Expression of S518 phosphorylated Merlin and its interaction with CD44 in vestibular schwannoma].
Cai LH; Wu H; Lü JR; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Dec; 43(12):910-4. PubMed ID: 19141242
[TBL] [Abstract][Full Text] [Related]
32. [Type 2 neurofibromatosis without acoustic neuroma].
Mautner VF; Lindenau M; Köppen J; Hazim W; Kluwe L
Zentralbl Neurochir; 1995; 56(2):83-7. PubMed ID: 7639047
[TBL] [Abstract][Full Text] [Related]
33. Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannoma.
Blakeley J
Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):372-9. PubMed ID: 22931905
[TBL] [Abstract][Full Text] [Related]
34. NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.
Lassaletta L; Torres-Martín M; Peña-Granero C; Roda JM; Santa-Cruz-Ruiz S; Castresana JS; Gavilan J; Rey JA
Otol Neurotol; 2013 Sep; 34(7):1355-61. PubMed ID: 23921927
[TBL] [Abstract][Full Text] [Related]
35. Schwannomas exhibit distinct size-dependent gene-expression patterns.
Mehrian-Shai R; Freedman S; Shams S; Doherty J; Slattery W; Hsu NY; Reichardt JK; Andalibi A; Toren A
Future Oncol; 2015; 11(12):1751-8. PubMed ID: 26075443
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide association analysis identifies a susceptibility locus for sporadic vestibular schwannoma at 9p21.
Sadler KV; Bowes J; Rowlands CF; Perez-Becerril C; van der Meer CM; King AT; Rutherford SA; Pathmanaban ON; Hammerbeck-Ward C; Lloyd SKW; Freeman SR; Williams R; Hannan CJ; Lewis D; Eyre S; Evans DG; Smith MJ
Brain; 2023 Jul; 146(7):2861-2868. PubMed ID: 36546557
[TBL] [Abstract][Full Text] [Related]
37. [Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in type 2 neurofibromatosis caused by a deletion of 22q12.1-q12.2 including
Zhang QJ; Wang GJ; Shen WD; Hong MD; Xiong F; Wang QJ; Han DY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Nov; 56(11):1199-1204. PubMed ID: 34749460
[TBL] [Abstract][Full Text] [Related]
38. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.
Baser ME; Makariou EV; Parry DM
J Neurosurg; 2002 Feb; 96(2):217-22. PubMed ID: 11838793
[TBL] [Abstract][Full Text] [Related]
39. A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.
Chen J; Landegger LD; Sun Y; Ren J; Maimon N; Wu L; Ng MR; Chen JW; Zhang N; Zhao Y; Gao X; Fujita T; Roberge S; Huang P; Jain RK; Plotkin SR; Stankovic KM; Xu L
Nat Protoc; 2019 Feb; 14(2):541-555. PubMed ID: 30617350
[TBL] [Abstract][Full Text] [Related]
40. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.
Mautner VF; Baser ME; Thakkar SD; Feigen UM; Friedman JM; Kluwe L
J Neurosurg; 2002 Feb; 96(2):223-8. PubMed ID: 11838794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]